Immunosenescence in Autoimmune Rheumatic Diseases: Mechanisms, Clinical Consequences, Biomarkers, and Emerging Therapeutic Strategies
DOI:
https://doi.org/10.64784/264Palabras clave:
immune senescence, immunosenescence, inflammaging, autoimmune diseases, rheumatic diseases, rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, systemic sclerosis, aging, adaptive immunity, innate immunity, biomarkers, precision medicine, senolytics, JAK inhibitors, mTOR, inflammaging biomarkers, immunology, rheumatology.Resumen
Immune senescence has emerged as one of the principal biological mechanisms linking aging with the development and progression of autoimmune rheumatic diseases. Rather than representing a simple decline in immune function, aging induces profound remodeling of both innate and adaptive immunity, characterized by chronic low-grade inflammation, loss of immune tolerance, impaired cellular regeneration, mitochondrial dysfunction, telomere shortening, epigenetic alterations, and expansion of senescent immune-cell populations. The objective of this review was to analyze current evidence regarding the mechanisms through which immune senescence reshapes autoimmune rheumatic diseases and to examine its clinical implications, biomarkers, and emerging therapeutic strategies. A narrative literature review was conducted using the scientific method and included publications retrieved from PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect, SpringerLink, Nature, Frontiers, and Wiley. The evidence consistently demonstrated that inflammaging, adaptive immune remodeling, and cellular senescence contribute to disease progression, increased susceptibility to infections, reduced vaccine responsiveness, cardiovascular complications, frailty, osteoporosis, sarcopenia, and diminished functional capacity. Conventional inflammatory biomarkers remain widely used; however, increasing attention has been directed toward multi-omics technologies, epigenetic clocks, mitochondrial biomarkers, proteomics, metabolomics, and immune-cell phenotyping for more accurate assessment of biological immune aging. Current therapeutic approaches continue to rely on disease-modifying antirheumatic drugs and biologic agents, while emerging interventions—including JAK inhibitors, mTOR modulation, senolytic therapies, microbiome-targeted strategies, and precision medicine—offer promising opportunities for future individualized management. Overall, immune senescence should be recognized as a fundamental component of autoimmune rheumatic diseases, providing important opportunities for improving diagnosis, risk stratification, therapeutic decision-making, and long-term clinical outcomes in aging populations.
Referencias
• Aiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G. (2019). Immunosenescence and its hallmarks: How to oppose aging strategically? Frontiers in Immunology, 10, 2247.
• Akbar, A. N., & Henson, S. M. (2019). Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nature Reviews Immunology, 19(11), 713–715.
• Alsaleh, G., Richter, F. C., & Simon, A. K. (2022). Age-related mechanisms in the context of rheumatic disease. Nature Reviews Rheumatology, 18(12), 694–710. https://doi.org/10.1038/s41584-022-00863-8
• Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019). Immunosenescence and human vaccine immune responses. Immunotherapy, 11(11), 1003–1020.
• De Martinis, M., Franceschi, C., Monti, D., & Ginaldi, L. (2005). Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Letters, 579(10), 2035–2039.
• Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: A new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576–590.
• Fulop, T., Larbi, A., Dupuis, G., Le Page, A., Frost, E. H., Cohen, A. A., Witkowski, J. M., & Franceschi, C. (2018). Immunosenescence and inflamm-aging as two sides of the same coin. Frontiers in Immunology, 8, 1960.
• Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., Miller, A. H., Mantovani, A., Weyand, C. M., Barzilai, N., Goronzy, J. J., Rando, T. A., Effros, R. B., Lucia, A., Kleinstreuer, N., & Slavich, G. M. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822–1832.
• Goronzy, J. J., Li, G., Yu, M., & Weyand, C. M. (2012). Signaling pathways in T-cell senescence. Ageing Research Reviews, 11(1), 33–39.
• Goronzy, J. J., & Weyand, C. M. (2019). Mechanisms underlying T-cell ageing. Nature Reviews Immunology, 19(9), 573–583.
• Huang, Z., Chen, B., Li, D., et al. (2025). Immune cell senescence in autoimmunity: Implications for disease pathogenesis and therapeutic targeting. Cellular & Molecular Immunology.
• Jeljeli, M. M., & Adamopoulos, I. E. (2023). Innate immune memory in inflammatory arthritis. Nature Reviews Rheumatology, 19(10), 627–639. https://doi.org/10.1038/s41584-023-01009-0
• Luo, Y., Zheng, S. G., & colaboradores. (2023). Immunosenescence: Molecular mechanisms and diseases. Signal Transduction and Targeted Therapy, 8, 200. https://doi.org/10.1038/s41392-023-01451-2
• Nikolich-Žugich, J. (2018). The twilight of immunity: Emerging concepts in aging of the immune system. Nature Immunology, 19(1), 10–19.
• Pawelec, G. (2018). Age and immunity: What is "immunosenescence"? Experimental Gerontology, 105, 4–9.
• Pezone, A., Olivieri, F., Napoli, M. V., Procopio, A., Avvedimento, E. V., Gabrielli, A., et al. (2023). Inflammation and DNA damage: Cause, effect or both. Nature Reviews Rheumatology, 19(4), 200–211. https://doi.org/10.1038/s41584-022-00905-1
• Saavedra, D., García, B., Lorenzo-Luaces, P., & Mazorra, Z. (2023). Immunosenescence and inflammaging: Mechanisms and role in diseases. Ageing Research Reviews, 101, 102540.
• Weyand, C. M., Fulbright, J. W., & Goronzy, J. J. (2003). Immunosenescence, autoimmunity, and rheumatoid arthritis. Experimental Gerontology, 38(8), 833–841.
• Weyand, C. M., & Goronzy, J. J. (2020). Accelerated immunosenescence in rheumatoid arthritis: Impact on clinical progression. Nature Reviews Rheumatology, 16(10), 573–589. https://doi.org/10.1038/s41584-020-0375-y
• Weyand, C. M., Haacke, E. A., & Goronzy, J. J. (2024). Immune aging and autoimmunity: New concepts in rheumatic disease pathogenesis. Nature Reviews Rheumatology.
